denileukin diftitox

denileukin diftitox (ONTAK) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

ONTAK is a marketed brand name for denileukin diftitox. Check FDA Drugs@FDA for the current US label holder and prescribing information.

denileukin diftitox has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.